Central African Republic vs Guyana: Incidence of HIV, ages 15-49, female

Central African Republic
1.3 per 1,000 uninfected female population ages 15-49
in 2024
Guyana
1.1 per 1,000 uninfected female population ages 15-49
in 2024
Central African Republic rank
16th
Guyana rank
18th

Incidence of HIV, ages 15-49, female over time

  • Central African Republic
  • Guyana
051015199020072024

How they compare

Central African Republic currently reports 1.3 per 1,000 uninfected female population ages 15-49 against 1.1 per 1,000 uninfected female population ages 15-49 in Guyana, a difference of 0.2 per 1,000 uninfected female population ages 15-49.

That makes Central African Republic's figure about 1.2 times Guyana's.

Across all 35 years both countries report, Central African Republic has been ahead every year.

Central African Republic ranks 16th and Guyana ranks 18th of 139 countries.

Central African Republic has averaged higher in every one of the 4 decades both report.

Head to head by decade

Decade Central African Republic Guyana Difference Ahead
1990s 12.39 per 1,000 uninfected female population ages 15-49 1.26 per 1,000 uninfected female population ages 15-49 11.13 per 1,000 uninfected female population ages 15-49 Central African Republic
2000s 5.77 per 1,000 uninfected female population ages 15-49 1.1 per 1,000 uninfected female population ages 15-49 4.67 per 1,000 uninfected female population ages 15-49 Central African Republic
2010s 3.15 per 1,000 uninfected female population ages 15-49 0.938 per 1,000 uninfected female population ages 15-49 2.21 per 1,000 uninfected female population ages 15-49 Central African Republic
2020s 1.58 per 1,000 uninfected female population ages 15-49 1.14 per 1,000 uninfected female population ages 15-49 0.44 per 1,000 uninfected female population ages 15-49 Central African Republic

Averages of every year both report within each decade.

Frequently asked questions

Which has higher incidence of hiv, ages 15-49, female, Central African Republic or Guyana?
Central African Republic, at 1.3 per 1,000 uninfected female population ages 15-49 against 1.1 per 1,000 uninfected female population ages 15-49 in Guyana as of 2024.
What is the difference in incidence of hiv, ages 15-49, female between Central African Republic and Guyana?
0.2 per 1,000 uninfected female population ages 15-49, with Central African Republic ahead.
How many years of comparable data are there for Central African Republic and Guyana?
35 years are reported by both, from 1990 to 2024.
How do Central African Republic and Guyana rank globally for incidence of hiv, ages 15-49, female?
Central African Republic ranks 16th and Guyana ranks 18th of 139 countries.
Where does this data come from?
UNAIDS estimates, published as Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Central African Republic vs Guyana: Incidence of HIV, ages 15-49, female. Statizoid, drawing on UNAIDS estimates. Retrieved 18 September 2026, from https://gender.statizoid.com/compare/incidence-of-hiv-ages-15-49-female-per-1-000-uninfected-female-population-ages-15-49/central-african-republic/guyana/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/compare/incidence-of-hiv-ages-15-49-female-per-1-000-uninfected-female-population-ages-15-49/central-african-republic/guyana/">Central African Republic vs Guyana: Incidence of HIV, ages 15-49, female</a> — Statizoid

About this data

Indicator
Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)
Unit
per 1,000 uninfected female population ages 15-49
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
157 places, 5,362 data points, 1990–2024
Last refreshed

Number of new HIV infections among uninfected female populations ages 15-49 expressed per 1,000 uninfected female population ages 15-49 in the year before the period.